XML 20 R1.htm IDEA: XBRL DOCUMENT v3.22.4
Document and Entity Information - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2022
Feb. 21, 2023
Jun. 30, 2022
Cover [Abstract]      
Document Type 10-K    
Amendment Flag false    
Document Period End Date Dec. 31, 2022    
Document Fiscal Year Focus 2022    
Document Fiscal Period Focus FY    
Trading Symbol AGLE    
Entity Registrant Name AEGLEA BIOTHERAPEUTICS, INC.    
Entity Central Index Key 0001636282    
Current Fiscal Year End Date --12-31    
Entity Filer Category Non-accelerated Filer    
Entity Well-known Seasoned Issuer No    
Entity Current Reporting Status Yes    
Entity Voluntary Filers No    
Entity Common Stock Shares Outstanding   65,395,159  
Entity Public Float     $ 30.3
Entity Shell Company false    
Entity Emerging Growth Company false    
Entity Small Business true    
ICFR Auditor Attestation Flag false    
Title of 12(b) Security Common Stock, $0.0001 Par Value Per Share    
Security Exchange Name NASDAQ    
Entity File Number 001-37722    
Entity Tax Identification Number 46-4312787    
Entity Address, Address Line One 805 Las Cimas Parkway    
Entity Address, Address Line Two Suite 100    
Entity Address, City or Town Austin    
Entity Address, Postal Zip Code 78746    
City Area Code 512    
Local Phone Number 942-2935    
Entity Address, State or Province TX    
Entity Incorporation, State or Country Code DE    
Document Annual Report true    
Document Transition Report false    
Entity Interactive Data Current Yes    
Documents Incorporated by Reference

Portions of the Registrant’s Definitive Proxy Statement (“Proxy Statement”) relating to the 2023 Annual Meeting of Stockholders will be filed with the Commission within 120 days after the end of the Registrant’s 2022 fiscal year and is incorporated by reference into Part III of this Report.

    
Auditor Firm ID 238    
Auditor Name PricewaterhouseCoopers LLP    
Auditor Location Austin, Texas